253 related articles for article (PubMed ID: 19851830)
1. Effect of adjuvants on immune response and protective immunity elicited by recombinant Hsp60 (GroEL) of Salmonella typhi against S. typhi infection.
Bansal A; Paliwal PK; Sagi SS; Sairam M
Mol Cell Biochem; 2010 Apr; 337(1-2):213-21. PubMed ID: 19851830
[TBL] [Abstract][Full Text] [Related]
2. Cloning, expression and characterization of heat shock protein 60 (groEL) of Salmonella enterica serovar Typhi and its role in protective immunity against lethal Salmonella infection in mice.
Paliwal PK; Bansal A; Sagi SS; Mustoori S; Govindaswamy I
Clin Immunol; 2008 Jan; 126(1):89-96. PubMed ID: 18024219
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal immunization of recombinant HSP70 (DnaK) of Salmonella Typhi induces a predominant Th2 response and protective immunity in mice against lethal Salmonella infection.
Paliwal PK; Bansal A; Sagi SS; Sairam M
Vaccine; 2011 Sep; 29(38):6532-9. PubMed ID: 21767594
[TBL] [Abstract][Full Text] [Related]
4. rIL-22 as an adjuvant enhances the immunogenicity of rGroEL in mice and its protective efficacy against S. Typhi and S. Typhimurium.
Kaur G; STS C; Nimker C; Bansal A
Cell Mol Immunol; 2015 Jan; 12(1):96-106. PubMed ID: 24858422
[TBL] [Abstract][Full Text] [Related]
5. Co-expression of S. Typhi GroEL and IL-22 gene augments immune responses against Salmonella infection.
Kaur G; STS C; Nimker C; Singh M; Saraswat D; Saxena S; Bansal A
Immunol Cell Biol; 2013; 91(10):642-51. PubMed ID: 24145856
[TBL] [Abstract][Full Text] [Related]
6. Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection.
Chitradevi ST; Kaur G; Uppalapati S; Yadav A; Singh D; Bansal A
Cell Mol Immunol; 2015 Nov; 12(6):757-67. PubMed ID: 25640657
[TBL] [Abstract][Full Text] [Related]
7. Development of recombinant vaccine candidate molecule against Shigella infection.
Chitradevi STS; Kaur G; Sivaramakrishna U; Singh D; Bansal A
Vaccine; 2016 Oct; 34(44):5376-5383. PubMed ID: 27591952
[TBL] [Abstract][Full Text] [Related]
8. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen.
Londoño-Arcila P; Freeman D; Kleanthous H; O'Dowd AM; Lewis S; Turner AK; Rees EL; Tibbitts TJ; Greenwood J; Monath TP; Darsley MJ
Infect Immun; 2002 Sep; 70(9):5096-106. PubMed ID: 12183559
[TBL] [Abstract][Full Text] [Related]
9. Salmonella Typhi OmpS1 and OmpS2 porins are potent protective immunogens with adjuvant properties.
Moreno-Eutimio MA; Tenorio-Calvo A; Pastelin-Palacios R; Perez-Shibayama C; Gil-Cruz C; López-Santiago R; Baeza I; Fernández-Mora M; Bonifaz L; Isibasi A; Calva E; López-Macías C
Immunology; 2013 Aug; 139(4):459-71. PubMed ID: 23432484
[TBL] [Abstract][Full Text] [Related]
10. Recombinant heat shock protein 60 (Hsp60/GroEL) of Salmonella enterica serovar Typhi elicits cross-protection against multiple bacterial pathogens in mice.
Chitradevi ST; Kaur G; Singh K; Sugadev R; Bansal A
Vaccine; 2013 Apr; 31(16):2035-41. PubMed ID: 23474314
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice.
Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620
[TBL] [Abstract][Full Text] [Related]
12. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever.
Das S; Chowdhury R; Pal A; Okamoto K; Das S
Immunobiology; 2019 May; 224(3):371-382. PubMed ID: 30952553
[TBL] [Abstract][Full Text] [Related]
13. Naloxone and alum synergistically augment adjuvant activities of each other in a mouse vaccine model of Salmonella typhimurium infection.
Jazani NH; Parsania S; Sohrabpour M; Mazloomi E; Karimzad M; Shahabi S
Immunobiology; 2011 Jun; 216(6):744-51. PubMed ID: 21093956
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel vaccine candidate against Salmonella enterica serovar Typhi by reverse vaccinology method and evaluation of its immunization.
Esmailnia E; Amani J; Gargari SLM
Genomics; 2020 Sep; 112(5):3374-3381. PubMed ID: 32565239
[TBL] [Abstract][Full Text] [Related]
15. Streptococcus pneumoniae fructose-1,6-bisphosphate aldolase, a protein vaccine candidate, elicits Th1/Th2/Th17-type cytokine responses in mice.
Elhaik Goldman S; Dotan S; Talias A; Lilo A; Azriel S; Malka I; Portnoi M; Ohayon A; Kafka D; Ellis R; Elkabets M; Porgador A; Levin D; Azhari R; Swiatlo E; Ling E; Feldman G; Tal M; Dagan R; Mizrachi Nebenzahl Y
Int J Mol Med; 2016 Apr; 37(4):1127-38. PubMed ID: 26935978
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of alum-based adjuvant on the immunogenicity of salmonella enterica serovar typhi conjugates vaccines.
Tritama E; Riani C; Rudiansyah I; Hidayat A; Kharisnaeni SA; Retnoningrum DS
Hum Vaccin Immunother; 2018 Jun; 14(6):1524-1529. PubMed ID: 29359991
[TBL] [Abstract][Full Text] [Related]
17. An Unmutated IgM Response to the Vi Polysaccharide of
Pandya KD; Palomo-Caturla I; Walker JA; K Sandilya V; Zhong Z; Alugupalli KR
J Immunol; 2018 Jun; 200(12):4078-4084. PubMed ID: 29743315
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
[TBL] [Abstract][Full Text] [Related]
19. Expression, purification and evaluation of recombinant lipoprotein of Salmonella typhi as a vaccine candidate.
Kumar A; Kundu S; Debnath Das M
Biologicals; 2017 Mar; 46():108-113. PubMed ID: 28189484
[TBL] [Abstract][Full Text] [Related]
20. In silico and in vivo approaches to recombinant multi-epitope immunogen of GroEL provides efficient cross protection against S. Typhimurium, S. flexneri, and S. dysenteriae.
Ardestani H; Nazarian S; Hajizadeh A; Sadeghi D; Kordbacheh E
Mol Immunol; 2022 Apr; 144():96-105. PubMed ID: 35217247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
